Banque Pictet & Cie’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Sell |
1,391
-92
| -6% | -$30K | ﹤0.01% | 285 |
|
|
2025
Q1 | $400K | Buy |
+1,483
| New | +$400K | ﹤0.01% | 315 |
|
|
2024
Q2 | – | Sell |
-33,005
| Closed | -$4.93M | – | 284 |
|
|
2024
Q1 | $4.93M | Buy |
33,005
+10,176
| +45% | +$1.52M | 0.05% | 145 |
|
|
2023
Q4 | $4.37M | Sell |
22,829
-2,595
| -10% | -$497K | 0.04% | 154 |
|
|
2023
Q3 | $4.5M | Sell |
25,424
-1,154
| -4% | -$204K | 0.05% | 152 |
|
|
2023
Q2 | $5.05M | Buy |
26,578
+21,471
| +420% | +$4.08M | 0.04% | 166 |
|
|
2023
Q1 | $1.02M | Sell |
5,107
-2,316
| -31% | -$464K | 0.01% | 381 |
|
|
2022
Q4 | $1.76M | Sell |
7,423
-4,910
| -40% | -$1.17M | 0.02% | 308 |
|
|
2022
Q3 | $2.47M | Buy |
12,333
+4,991
| +68% | +$999K | 0.03% | 253 |
|
|
2022
Q2 | $1.07K | Sell |
7,342
-4,432
| -38% | -$647 | 0.01% | 419 |
|
|
2022
Q1 | $1.92M | Sell |
11,774
-4,707
| -29% | -$769K | 0.01% | 341 |
|
|
2021
Q4 | $2.8M | Buy |
+16,481
| New | +$2.8M | 0.02% | 283 |
|